Company: SHPH
Filing Date: 2025-02-27
Form Type: 424B3
Source: 0001493152-25-008476
Chunk: 138

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-27
Form: 424B3
Chunk 138
---
 Our independent directors consist of Messrs. Richards and Schafer, Dr. Senanayake and Dr. Jacobs.

| 75 |

Board Committees

General

Our board of directors has established three committees consisting of an audit committee, a compensation committee, and a nominating and corporate governance committee. The members of each committee qualify as “independent” as defined under Nasdaq listing standards and Rule 10A-3(b)(1). Moreover, at least one member of the audit committee qualifies as an “audit committee financial expert” as the term is defined under Nasdaq listing standards and applicable rules and regulations of the SEC, based on their respective business professional experience in the financial and accounting fields.

Audit Committee

The audit committee, which consists of Steve Richards, MBA, CPA (Chair), Bette Jacobs and Chris H. Senanayake, assists our board of directors in its oversight of the Company’s accounting and financial reporting processes and the audits of the Company’s financial statements, including (a) the quality and integrity of the Company’s financial statements (b) the Company’s compliance with legal and regulatory requirements, (c) the independent auditors’ qualifications and independence and (d) the performance of the Company’s internal audit functions and independent auditors, as well as other matters which may come before it as directed by the board of directors. Further, the audit committee, to the extent it deems necessary or appropriate, among its several other responsibilities, will:

| ● | be                                                                                                                                    
 responsible for the appointment, compensation, retention, termination and oversight of the work of any independent auditor engaged    
 for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Company;         |
| ● | discuss                                                                                                                               
 the annual audited financial statements and the quarterly unaudited financial statements with management and the independent auditor  
 prior to their filing with the SEC in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q;                              |
| ● | review                                                                                                                                
 with the Company’s management on a periodic basis (i) issues regarding accounting principles and financial statement presentations,   
 including any significant changes in our Company’s selection or application of accounting principles; and (ii) the effect of          
 any regulatory and accounting initiatives, as well as off-balance sheet structures, on the financial statements of the Company;       |
| ● | monitor                                                                                                                               
 the Company’s policies for compliance with federal, state, local and foreign laws and regulations and the Company’s policies          
 on corporate